{"member_organisations": "", "identification_number": "935213429327-87", "fields_of_interest": "General and Institutional Affairs, Economy, finance and the euro, Trade, International co-operation and development, Customs, Education and training, Employment and Social Affairs, Business and Industry, Single market, Foreign and Security Policy and Defence, Research and innovation, Trans-European Networks, Public Health, Communication, Banking and financial services", "head_office_address": "Falkenried 88, Bldg. D", "full_time_equivalent_fte": "0,25", "person_with_legal_responsibility": "Hartmut Dr. Juhl", "industry_forums": "", "grants": "", "inter_groups": "", "eu_initiatives": "Das Projekt zur individuellen Medizin (IMI Projekt), die Horizon 2020 Intitiative, die Neuregelung der Datenschutzrichtlinien", "level_of_interest": "global", "organisation_name": "Indivumed", "belgium_office_post_code": "", "number_of_persons_involved": "1", "person_in_charge_of_eu_relations": "Hartmut Dr. Juhl", "section": "II - In-house lobbyists and trade/business/professional associations", "source": "", "subsection": "Companies & groups", "belgium_office_phone": "", "overall_budget_turnover_as_a_range": "", "belgium_office_address": "", "no_geo_reference": true, "persons_accredited_for_access_to_european_parliament_premises": "", "registration_date": "17/12/2017", "estimate_of_costs_absolute_amount": "", "website_address": "http://www.indivumed.com", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Hamburg", "membership": "Verband Deutscher Biotechnologie e.V. \nLife Science Nord e.V. \nwww.esbb.org", "head_office_post_code": "20251", "position": "Gesch\u00e4ftsf\u00fchrer", "financial_year_start_date": "01/01/2016", "head_office_country": "Germany", "number_of_ep_accredited_persons": "", "relevant_communication": "", "financial_year_end_date": "01/12/2016", "estimate_of_costs_as_a_range": "10000-24999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "GmbH", "procurement": "", "customers": "", "belgium_office_post_box": "", "goals__remit": "Verbesserung der Krebstherapie durch eine personalisierte Krebstherapie in Zusammenarbeit mit Pharma- und Biotechnologeunternehmen sowie akademsichen Einrichtungen. Die Grundlage bilden eine globale Krebsdatenbank, die auf einer engen Zusammenarbeit mit einem internationalen klinischen Netzwerk basiert, einem breit aufgestellten Forschungslabor und Expertise in Bioinformatik.", "belgium_office_city": "", "head_office_phone": "(+4940)4133830"}